Bevacizumab-induced regression of anaplastic meningioma

Ann Oncol. 2010 Dec;21(12):2445-2446. doi: 10.1093/annonc/mdq634. Epub 2010 Nov 1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use
  • Bevacizumab
  • Female
  • Humans
  • Meningeal Neoplasms / drug therapy*
  • Meningioma / drug therapy*
  • Middle Aged
  • Remission Induction / methods
  • Treatment Outcome

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Bevacizumab